Bookmarks (2) clear filters

Summary List Placement The US Food and Drug Administration will be hosting a meeting in just under three weeks to consider an emergency use authorization for Pfizer's COVID-19 vaccine, the agency announced Friday. Earlier this week, the pharmaceutical giant revealed that its experimental vaccine is 95% effective at preventing transmission of the coronavirus, citing a clinical trial involving more than 43,000 people. Only mild...

Summary List Placement The US clinical trial of AstraZeneca's COVID-19 vaccine will be suspended for the next several days as the US Food and Drug Administration investigates a potential side effect, according to Reuters. Sources told the news agency on Monday that enrollment in the trial was not being reopened "until at least midweek," pending the investigation. The FDA did not immediately respond to...